New Zealand markets open in 1 hour 35 minutes

Globus Medical, Inc. (GMED)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
61.73+10.37 (+20.19%)
At close: 04:00PM EDT
61.73 +0.12 (+0.19%)
After hours: 04:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.94B
Enterprise value 6.94B
Trailing P/E 48.00
Forward P/E 19.12
PEG ratio (5-yr expected) 1.74
Price/sales (ttm)3.75
Price/book (mrq)1.73
Enterprise value/revenue 4.42
Enterprise value/EBITDA 20.02

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-10.46%
S&P500 52-week change 325.38%
52-week high 365.74
52-week low 343.39
50-day moving average 352.41
200-day moving average 352.09

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 3939.48k
Shares outstanding 5112.62M
Implied shares outstanding 6139.57M
Float 8111.61M
% held by insiders 10.80%
% held by institutions 198.03%
Shares short (15 Apr 2024) 47.51M
Short ratio (15 Apr 2024) 47.36
Short % of float (15 Apr 2024) 47.47%
Short % of shares outstanding (15 Apr 2024) 45.56%
Shares short (prior month 15 Mar 2024) 45.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.51%
Operating margin (ttm)4.87%

Management effectiveness

Return on assets (ttm)4.32%
Return on equity (ttm)2.28%

Income statement

Revenue (ttm)1.9B
Revenue per share (ttm)15.58
Quarterly revenue growth (yoy)119.30%
Gross profit (ttm)N/A
EBITDA 427.15M
Net income avi to common (ttm)66.63M
Diluted EPS (ttm)1.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)434.47M
Total cash per share (mrq)3.22
Total debt (mrq)525.6M
Total debt/equity (mrq)13.40%
Current ratio (mrq)2.33
Book value per share (mrq)29.04

Cash flow statement

Operating cash flow (ttm)242.57M
Levered free cash flow (ttm)-353.24M